Markets
Goldman Sachs David Solomon
Goldman Sachs CEO David Solomon talked up the outlook for dealmaking Wednesday (Tom Williams/Getty Images)
Deal!

Merger bait surges as stocks and CEO confidence rise

CEOs are feeling good enough to start making some bad decisions.

Matt Phillips

There’s a lot for stock-market bulls to like in today’s markets, with everything from Big Tech to small caps posting solid gains.

But one of areas of thematic strength, at least looking at Goldman Sachs’ baskets of thematically organized stocks, is potential M&A candidates in the US.

This basket, which is made up of about 60 stocks that Goldman analysts think have a 15% chance of being acquired over the next year to 18 months, is up about 1.8% at last glance, outpacing the overall S&P 500.

True, they’re a volatile bunch of relatively small companies skewing heavily toward biotech and software. Members like Wolfspeed, Denali Therapeutics, and Mineralys Therapeutics posted big jumps on the day.

But even beyond such micro targets, the big-picture outlook for dealmaking is expected to be a bright spot for the market in 2025.

After the best two-year stretch since the late 1990s for markets, stocks are well juiced to be used as currencies in deals.

Moreover, CEO confidence is at its highest level of the last couple years, a signal that often indicates they’re about to make some power moves.

And from their perspective, the timing may look perfect. Lina Khan’s stint at the FTC — and its more stringent approach to antitrust compared to recent administrations — is coming to a close.

As always, investment bankers will be ready to advocate that bosses are exactly right to pull the trigger on transformative deals.

In fact, executives at Goldman Sachs — a major employer of such financiers, which itself reported stellar results on Wednesday — told analysts that the deals pipeline is filling right up and that it should be a good year for fee-laden corporate buyouts.

“Theres been a meaningful pickup in large-cap M&A dialogue and inquiry,” Goldman CEO David Solomon told analysts, adding, “And we continue to see strong positive backlog.”

Perhaps unsurprisingly, the bank’s strategists are singing from a similar hymnal as the CEO.

“Those making the longer horizon decisions (M&A, buybacks, public offerings, etc.) are as positive as they have been in years,” wrote Brian Garrett, head of equity execution on the cross-asset sales desk, who highlighted M&A candidates as an attractive thematic trade.

More Markets

See all Markets
markets

Spectrum owner Charter Communications is on pace for its worst day ever as broadband numbers and Q1 results disappoint

Cable and broadband company Charter Communications is on pace for its worst-ever trading day on Friday, as investors dump the stock following its Q1 results and forward guidance.

Charter, which owns Spectrum, reported adjusted earnings of $9.17 per share, below Wall Street estimates of $9.96 per share from analysts polled by FactSet. On the company’s earnings call, CFO Jessica Fischer appeared to lower its guidance for full-year revenue per user.

“It’ll be close either way in terms of whether we end up with net growth,” Fischer said.

The company lost 120,000 internet subscribers in the quarter, deeper than the expected 94,800 and double its loss from the same period last year. That news comes one day after Comcast’s earnings provided a bit of optimism for broadband as a category: the company reported Q1 losses of 65,000, significantly improving from 183,000 losses in the same quarter last year. Comcast is down more than 10%, on pace for its worst day since January 2025.

markets
Luke Kawa

Nvidia poised to snap longest run without a record close since the AI boom began

The stock price of the company responsible for the brains of the AI boom is finally showing some brawn again.

Nvidia, the world’s most valuable company, is poised to close at a record high for the first time since October 29, 2025, on Friday (if it ends above $207.04).

The AI chip trade is on fire, with the Philadelphia Semiconductor Index slated to deliver its 18th consecutive gain as Intel’s robust results and outlook juice the entire ecosystem. Hyperscalers report earnings next week, and their capex guidance can be thought of as the earnings guidance for Nvidia and other AI suppliers for the quarters to come.

This would end Nvidia’s longest stretch without a record close since the unofficial start of the AI boom (when the chip designer delivered blowout quarterly results in May 2023).

(Sorry if I jinx this!)

markets

Lilly slips after prescriptions for its weight-loss pill come in below expectations in second week

Eli Lilly fell on Friday after prescription data for its new weight-loss pill, Foundayo, showed that it’s having a significantly slower rollout than its top competitor.

The pill was prescribed about 3,700 times in its second week, according to IQVIA data cited by Deutsche Bank analysts, compared to the roughly 8,000 they were expecting. Novo Nordisk’s Wegovy pill, which came out in January, hit over 18,000 prescriptions in its second week.

The FDA approved Foundayo on April 1 and shipments began on April 9. Deutsche analysts noted that Lilly’s GLP-1 injections, which currently outsell Novo’s, also had a slower start.

Lilly fell more than 4% after the numbers were released. Novo Nordisk rose more than 5%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.